Research Article
Volume 7 Issue 9 - 2020
Prevalence of Resistant Hypertension in Hypertension and Research Center, Rangpur
Ratindra Nath Mondal1*, Mahfuj-Ul-Anwar2, Shah Md Sarwer Jahan2, ASM Rahenur Mondol2, Md Mokhlesur Rahman Sarker2, Md Al Fatah Al Adiluzzaman2, Narayan Chandra Sarkar2, Moni Rani3, Sajeda Afrin2 and Md Zakir Hossain4
1Hypertension and Research Center, Rangpur, Bangladesh
2Rangpur Medical College, Rangpur, Bangladesh
3Rajshahi Medical College, Rajshahi, Bangladesh
4Shaheed Ziaur Rahman Medical College, Bogra, Bangladesh
*Corresponding Author: Ratindra Nath Mondal, Hypertension and Research Center, Rangpur, Bangladesh.
Received: July 10, 2020; Published: August 05, 2020


Background: Now a days hypertension is a major public health problem due to its complications like cardiovascular diseases, stroke, chronic kidney disease and peripheral vascular disease.

Subjects and Methods: This was a cross sectional study, carried out in Hypertension and Research Center Rangpur, Bangladesh. Assuming unknown prevalence of resistant hypertension a sample size of 384 will be calculated to give the true prevalence with a precision of 5% with 95% of confidence level. On an average about 30 patient visit to Hypertension and Research Center, Rangpur daily. From the daily visited patients every 3rd patient was included in this study.

Results: In this study, we have examined a total of 351 people of both sexes. In our study 97.2% (341) patients taking the drugs regularly. So, the prevalence of resistant hypertension among the patient who taking the antihypertensive drug regularly was 15.83% (54). Uncontrolled hypertension was in 21.9%. Prevalence of resistant hypertension was more in male than female (59.3% vs 40.7%). Resistant hypertension were more common in comparatively older age patients (55.88 vs 50.49 years), those who continued smoking (11.2% vs 2.7%), were physically inactive (18.5% vs 10.1%), did not do regular exercise (59.3% vs 51.9%), obese (16.7% vs 10.4%) and longer duration of hypertension. Resistant hypertension was also common among those intake NSAID (5.56% vs 1.68%) and steroid concurrently (3.70% vs 2.02%). Target organ damage e.g. IHD (31.48% vs 9.09%) and CKD (3.70% vs 2.35%) were more in resistant hypertensive than non-resistant hypertensive patient.

Conclusion: In our study approximately one-sixth of the hypertensive patients had resistant hypertension. older age, physical inactivity, irregular exercise (30 minutes of walking), irregular follow up and increasing duration of hypertension are associated with resistant hypertension.

Keywords: Resistant; Hypertension; Center; Rangpur


  1. World Health Organization. Health profile of Bangladesh. WHO Bangladesh (2003). 
  2. World Health Organization. World Health Report 2002: Reducing risks, promoting healthy life. WHO Geneva (2003).
  3. Chobanian AV. “Control of hypertension–an important national priority”. The New England Journal of Medicine 345 (2001): 534-535.
  4. Wolf-Maier K., et al. “Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States”. The Journal of the American Medical Association 289 (2003): 2363-2369.
  5. Gorelick PB. “New horizons for stroke prevention PROGRESS and HOPE”. Lancet Neurology 1 (2002): 149-156.
  6. MM Zaman and MA Rouf. “Prevalence of hypertension in a Bangladeshi adult population”. Journal of Human Hypertension 13.8 (1999): 547-549.
  7. NCD risk factor survey 2010 report published and disseminated (2011).
  8. Ratindra Nath Mondal., et al. “Prevalence and Risk Factors of Hypertension in Rangpur, Bangladesh”. World Heart Journal 5.2 (2013): 91-100.
  9. Nadar SK., et al. “Target organ damage in hypertension: pathophysiology and implications for drug therapy”. Current Pharmaceutical Design 12.13 (2006): 1581-1592.
  10. Mondal RN., et al. “Validity of verbal autopsy questionnaire for assessment of causes of death among patients with hypertension”. World Heart Journal 6 (2014): 107-116.
  11. Chobanian AV., et al. “Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure”. Hypertension 42.6 (2003): 1206-1252.
  12. Turnbull F., et al. “Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials”. British Medical Journal 336 (2008): 1121-1123. 
  13. Lewington S., et al. “Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies”. Lancet 360 (2002): 1903-1913. 
  14. Adler AI., et al. “Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64)”. Kidney International 63 (2003): 225-232. 
  15. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)”. The Journal of the American Medical Association 288 (2002): 2981-2997. 
  16. Dahlof B., et al. “Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint Reduction in Hypertension Study (LIFE): a randomised trial against atenolol”. Lancet 359 (2002): 995-1003. 
  17. Pepine CJ., et al. “A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial”. The Journal of the American Medical Association 290 (2003): 2805-2816. 
  18. Lloyd-Jones D., et al. “Heart disease and stroke statistics: 2010 update: a report from the American Heart Association”. Circulation 121 (2010): e46-e215.
  19. Cuspidi C., et al. “High prevalence of cardiac and extracardiac target organ damage in refractory hypertension”. Journal of Hypertension 19.11 (2001): 2063-2070.
  20. Sarafidis PA. “Epidemiology of resistant hypertension”. Journal of Clinical Hypertension 13.7 (2011): 523-528.
  21. NCD risk factor survey 2010 report published and disseminated (2011).
  22. Mondal RN., et al. “Prevalence and Risk Factors of Hypertension in Rangpur, Bangladesh”. World Heart Journal 5.2 (2013): 91-100.
  23. Oliveria SA., et al. “Physician-related barriers to the effective management of uncontrolled hypertension”. Archives of Internal Medicine 162.4 (2002): 413-420. 
  24. Berlowitz DR., et al. “Inadequate management of blood pressure in a hypertensive population”. The New England Journal of Medicine 339.27 (1998): 1957-1963.  
  25. Knight EL., et al. “Predictors of uncontrolled hypertension in ambulatory patients”. Hypertension 38.4 (2001): 809-814.  
  26. Hajjar I and Kotchen TA. “Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000”. The Journal of the American Medical Association 290.2 (2003): 199-206. 
  27. Lloyd-Jones DM., et al. “Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community”. Hypertension 36.4 (2000): 594-599.
  28. Haslam DW and James WP. “Obesity”. Lancet 366.9492 (2005): 1197-1209.
  29. Calhoun DA., et al. “Resistant hypertension: diagnosis, evaluation, and treatment. a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research”. Hypertension 51.6 (2008): 1403-1419.
  30. Xin X., et al. “Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials”. Hypertension 38.5 (2001): 1112-1117.
  31. Weinberger MH. “Salt sensitivity of blood pressure in humans”. Hypertension 27.3-2 (1996): 481-490.
  32. Vazquez PJ., et al. “Proton pump inhibitors therapy and blood pressure control”. International Journal of Pharmacological Research 4.3 (2014): 142-147.
  33. Mancia G., et al. “Guidelines for the management of arterial hypertension The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)”. European Heart Journal 28 (2007): 1462-1536.
Citation: Ratindra Nath Mondal., et al. “Prevalence of Resistant Hypertension in Hypertension and Research Center, Rangpur”. EC Cardiology 7.9 (2020): 06-13.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

November Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 09, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.